Efficient Liverand Tumor Post-Y90
MIM SurePlan LiverY90 provides timesaving tools for liver and tumor segmentation, deformable registration, and post-treatment dosimetry using Y90-PET and Bremsstrahlung SPECT. Use it alone, or integrate with the larger MIM ecosystem to take advantage of a comprehensive, vendor-neutral platform for Nuclear Medicine processing and review.
What Dose Did Your Patients Receive?
Overcome Roadblocks that Prevent You From Delivering Dose with Confidence.
Read with Confidence
Now you can read PET/CT, PET/MR, SPECT/CT, and planar Nuclear Medicine images from any major manufacturer—all in one system.
Treat with Confidence
Limitations in knowledge and certainty often accompany subsequent Y90 treatments. Many oncologists have questions surrounding follow-up
for dose delivery and coverage. MIM SurePlan LiverY90 can put an end to not knowing
Time-Saving Tools for Liver and Tumors
Optimize Treatment Evaluations with Volume Segmentation, Deformable Registration, and Post Dosimetry Treatment.
Know Your Dose the Day of Treatment
Patient-specific dosimetry overcomes the uncertainty that the existing planning methods do not correlate with the actual dose delivered.
Timesaving Tools
MIM SurePlan LiverY90 is specifically engineered for Y90, making efficiency a top priority. A recent study1 in the Journal of Nuclear Medicine
demonstrated a 70% reduction in time compared to manual outlining of the liver.
Empower Your Oncologists
With patient-specific dosimetry, referrers have increased confidence that Y90 is a more legitimate treatment option. Make the best treatment
path available to your patient by opening up subsequent treatment options using the knowledge gained.
Post-Op Dosimetry
Calculate dose using Y90-PET and Bremsstrahlung SPECT. Calculate isodose curves/DVH on PET/SPECT using Local Disposition Method or
MIRD Kernal.
Flexible Workflows
Quickly see and run pretreatment and posttreatment workflows from the sidebar menu.

非常抱歉,您只有购买软件后才能查看完整软件教程!
